Outcomes and Predictors of Perinatal Mortality in Fetuses With Ebstein Anomaly or Tricuspid Valve Dysplasia in the Current Era
Authors:
- Lindsay R. FreudLFLindsay R. Freud
- Maria C. Escobar-DiazMEMaria C. Escobar-Diaz
- Brian T. KalishBKBrian T. Kalish
- Rukmini KomarluRKRukmini Komarlu
- Michael D. PuchalskiMPMichael D. Puchalski
- Edgar T. JaeggiEJEdgar T. Jaeggi
- Anita L. SzwastASAnita L. Szwast
- Grace FreireGFGrace Freire
- Stéphanie M. LevasseurSLStéphanie M. Levasseur
- Ann Kavanaugh-McHughAKAnn Kavanaugh-McHugh
- Erik C. MichelfelderEMErik C. Michelfelder
- Anita J. Moon-GradyAMAnita J. Moon-Grady
Top Cited Papers
- 11 August 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 132 (6) , 481-489
Abstract
Background—: Ebstein anomaly and tricuspid valve dysplasia are rare congenital tricuspid valve malformations associated with high perinatal mortality. The literature consists of small, single-center case series spanning several decades. We performed a multicenter study to assess the outcomes and factors associated with mortality after fetal diagnosis in the current era. Methods and Results—: Fetuses diagnosed with Ebstein anomaly and tricuspid valve dysplasia from 2005 to 2011 were included from 23 centers. The primary outcome was perinatal mortality, defined as fetal demise or death before neonatal discharge. Of 243 fetuses diagnosed at a mean gestational age of 27±6 weeks, there were 11 lost to follow-up (5%), 15 terminations (6%), and 41 demises (17%). In the live-born cohort of 176 live-born patients, 56 (32%) died before discharge, yielding an overall perinatal mortality of 45%. Independent predictors of mortality at the time of diagnosis were gestational age P P P P =0.04). Nonsurvivors were more likely to have pulmonary regurgitation at any gestational age (61% versus 34%; P P <0.001). Conclusion—: In this large, contemporary series of fetuses with Ebstein anomaly and tricuspid valve dysplasia, perinatal mortality remained high. Fetuses with pulmonary regurgitation, indicating circular shunt physiology, are a high-risk cohort and may benefit from more innovative therapeutic approaches to improve survival.Keywords
This publication has 28 references indexed in Scilit:
- Perinatal course of Ebstein's anomaly and tricuspid valve dysplasia in the fetusPrenatal Diagnosis, 2012
- Left ventricular function and geometry in fetuses with severe tricuspid regurgitationUltrasound in Obstetrics & Gynecology, 2011
- Prediction of Outcome of Tricuspid Valve Malformations Diagnosed During Fetal LifeThe American Journal of Cardiology, 2008
- Prediction of outcome of fetal congenital heart disease using a cardiovascular profile scoreUltrasound in Obstetrics & Gynecology, 2008
- Relation of Limiting Ductal Patency to Survival in Neonatal Ebstein’s AnomalyThe American Journal of Cardiology, 2005
- Improving Outcomes in Fetuses and Neonates With Congenital Displacement (Ebstein’s Malformation) or Dysplasia of the Tricuspid ValveThe American Journal of Cardiology, 2005
- Characteristics and Outcomes of Fetuses With Pericardial EffusionsThe American Journal of Cardiology, 2005
- Prevalence of congenital heart diseaseAmerican Heart Journal, 2004
- Unguarded tricuspid valvar orifice in the fetusCardiology in the Young, 2004
- Outcome in Cyanotic Neonates With Ebstein’s AnomalyThe American Journal of Cardiology, 1998